Nicotine protects dopaminergic neurons against lipopolysaccharide-induced damage through a7 nAChRs in microglia

Life Science Journal

Volumn 10, Issue 3, 2013, Pages 1198-1203

  Li, Zhihua ^a   Cao, Jing ^a   Ren, Xiuhua ^a   Zhao, Qingzan ^a   Zhou, Mingfu ^a   Zang, Weidong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Dopaminergic neuron; Microglia; nAChRs; Nicotine; Parkinson's disease

Indexed keywords

EID: 84883228481     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Park HJ, Lee PH, Ahn YW, et al. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur J Neurosci. 2007; 26(1): 79-89.
2. Shytle RD, Mori T, Townsend K, et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem. 2004; 89(2): 337-43.
3. Le W, Rowe D, Xie W, et al. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci. 2001; 21(21): 8447-55.
4. Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl. 2006; (70): 373-381.
5. Imamura K, Hishikawa N, Ono K, et al. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol. 2005; 109(2):141-150.
6. Béraud D, Hathaway HA, Trecki J, et al. Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein. J Neuroimmune Pharmacol. 2013; 8(1): 94-117.
7. Olofsson PS, Rosas-Ballina M, Levine YA, et al. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev. 2012; 248(1):188-204.
8. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature. 2003; 421(6921): 384-388.
9. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med. 2009; 265(6): 663-679.
10. Fan JX, Li ZH, Ren XH, et al. Injure effects of LPS on mesencephalic neuron-glia cultures of rats. Journal of Zhengzhou University(Medical Sciences). 2011;46(1):38-42.
11. Li ZH, Zhao QZ, Zhang H, et al. Nicotine suppresses lipopolysaccharide-induced release of interleukin-6 in mixed glia and microglia-enriched cultures. Neural Regen Res. 2011; 6(5): 325-329.
12. Zhang D, Hu X, Wei SJ, et al. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. J Neuroinflammation. 2008; 5: 21.
13. Lepoutre V, Jain P, Quann K, et al. Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Front Biosci. 2009; 14:1152-1168.
14. Li XZ, Bai LM, Yang YP, et al. Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation. Neurosci Res. 2009; 65(3): 252-258.
15. Block ML, Hong JS. Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans. 2007; 35 (Pt 5): 1127-1132.
16. Chen HQ, Jin ZY, Li GH. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation. Neurosci Lett. 2007; 417(2): 112-117.
17. Suzuki T, Hide I, Matsubara A, et al. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J Neurosci Res. 2006; 83(8): 1461-70.
18. Xu Y, Xue Y, Wang Y, et al. Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia. Int Immunopharmacol. 2009; 9(3): 360-365.
19. Lee M, Sparatore A, Del Soldato P, et al. Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia. 2010; 58(1): 103-113.
20. Wilms H, Sievers J, Rickert U, et al. Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. J Neuroinflammation. 2010; 7:30.
21. Long-Smith CM, Collins L, Toulouse A, et al. Interleukin-1β contributes to dopaminergic neuronal death induced by lipopolysaccharide-stimulated rat glia in vitro. J Neuroimmunol. 2010; 226(1-2):20-26.
22. Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther. 2000; 293, 607-617.
23. Zheng LT, Ock J, Kwon BM, et al. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol. 2008; 8(3): 484-494.
24. Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther. 2000a; 293: 607-617.
25. Liu B, Jiang JW, Wilson BC, et al. Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther. 2000b; 295(1):125-132.
26. Zhang DZ, Zhao QZ, Ren XH, et al. Protective effects of nicotine on dopaminergic neurons in PD rats. Journal of Zhengzhou University (Medical Sciences) 2011; 45(6): 904-907.